Becker's Healthcare August 29, 2024
Andrew Cass

Over the past 18 months, healthtech investment volume has decreased as investors have endured inflation, elevated interest rates and greater uncertainty, Deloitte said in an Aug. 27 report.

Healthtech investors have shifted their strategies and priorities during this span, according to the report. Investors are now prioritizing proven business models that have a “demonstrated track record of healthy liquidity and sustainable revenue and profit.”

Deloitte said revenue cycle...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Investments, Provider, RCM (Revenue Cycle Mgmt), Survey / Study, Technology, Trends
Aspirion lands 7th acquisition in 6 years
Revenue Cycle Risk Takers
Revenue Cycle AI Is Costly and Cumbersome. Here's Why Leaders Are Still Buying In.
Medical Tourism and Global Private Healthcare Drive Revenue Cycle Innovation: Black Book Report
4 Cornerstones for Successful AI Implementation in Hospital Revenue Cycle Management in 2025

Share This Article